In the aforementioned study by Amkreutz and colleagues [15], ACPA positivity did not associate to a greater decrease in absolute BMD values, Z-scores or greater incidence of osteopenia over a follow-up period of 5 years for the Dutch cohort and 10 years for the Swedish cohort. The gene discussed is PRTN3; the disease is Osteopenia.